10330sek
0,5 %
Date:2025-06-05Time:18:00:00Latest report:Q1-2025List:Mid CapTicker:BIOG B
Market Cap:10 450 msekEnterprise Value:9 201 msekNet Sales:1 419 msekEarnings:309,7 msekEmployees:0ISIN:SE0017769995
Ratios
10-year key figure history for BioGaia turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for BioGaia with index and moving average MA50 and MA200.
Stockprice:103,30
MA50:103,60
MA200:111,55
Price/MA200:-7,4 %
RSI (14):50,9
Price/MA50:-0,3 %
Description
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.